Filipa is a Research Fellow in the Nanosafety Research Group, and her research focuses on the complex interactions among the immunological system and different organs, using novel technologies and in-house developed systems.
Filipa has a background in Pharmaceutical Sciences and holds a PhD in Pharmaceutical Technology from the Faculty of Pharmacy, University of Coimbra, focused on the development and optimization of a polymeric nasal vaccine against hepatitis B to be used for mass immunization. She moved to Ireland during her postdoc to conduct her research at the interface between biomaterial and immunology, studying key aspects of immunomodulation by a relevant spectrum of materials with applicability in the regenerative medicine field. In 2019, she was awarded an Industry Fellowship to work in collaboration with Johnson & Johnson, where she was responsible for the development of tailored 3D bioprinted in vitro models. Filipa collaborated with leading experts in different fields.
Microfluidic-based skin-on-chip systems for safety assessment of nanomaterials
TRENDS IN BIOTECHNOLOGY, 2023